Alpha Tau Medical Stock Performance
| DRTSW Stock | USD 0.35 0.05 16.67% |
Alpha Tau holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.04, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alpha Tau will likely underperform. Use Alpha Tau value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on Alpha Tau.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Alpha Tau showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Alpha Tau Medical Ltd. Sees Significant Growth in Short Interest - MarketBeat | 11/15/2024 |
2 | Alpha Tau Medical Ltd. Announces Key Shareholder Decisions at Annual Meeting - TipRanks | 12/17/2024 |
3 | DRTS Stock Soars to 52-Week High, Reaching 4.08 Amid Healthcare Surge - Investing.com | 01/17/2025 |
4 | Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Ad... | 02/03/2025 |
| Begin Period Cash Flow | 6.7 M |
Alpha |
Alpha Tau Relative Risk vs. Return Landscape
If you would invest 20.00 in Alpha Tau Medical on November 18, 2024 and sell it today you would earn a total of 15.00 from holding Alpha Tau Medical or generate 75.0% return on investment over 90 days. Alpha Tau Medical is currently producing 2.93% returns and takes up 19.5411% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Alpha, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Alpha Tau Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alpha Tau's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alpha Tau Medical, and traders can use it to determine the average amount a Alpha Tau's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1499
| Best Portfolio | Best Equity | |||
| Good Returns | DRTSW | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.54 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.93 actual daily | 58 58% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Alpha Tau is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alpha Tau by adding it to a well-diversified portfolio.
Alpha Tau Fundamentals Growth
Alpha Stock prices reflect investors' perceptions of the future prospects and financial health of Alpha Tau, and Alpha Tau fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alpha Stock performance.
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.23 | ||||
| EBITDA | (28.03 M) | ||||
| Net Income | (29.16 M) | ||||
| Total Debt | 13.28 M | ||||
| Book Value Per Share | 1.00 X | ||||
| Cash Flow From Operations | (17.96 M) | ||||
| Total Asset | 107.39 M | ||||
| Retained Earnings | (115.76 M) | ||||
| Working Capital | 78.65 M | ||||
About Alpha Tau Performance
Evaluating Alpha Tau's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Alpha Tau has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alpha Tau has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (5.81) | (6.10) | |
| Return On Tangible Assets | (0.31) | (0.33) | |
| Return On Capital Employed | 0.32 | 0.34 | |
| Return On Assets | (0.31) | (0.33) | |
| Return On Equity | (0.40) | (0.38) |
Things to note about Alpha Tau Medical performance evaluation
Checking the ongoing alerts about Alpha Tau for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alpha Tau Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alpha Tau Medical is way too risky over 90 days horizon | |
| Alpha Tau Medical has some characteristics of a very speculative penny stock | |
| Alpha Tau Medical appears to be risky and price may revert if volatility continues | |
| Alpha Tau Medical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (29.16 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alpha Tau generates negative cash flow from operations | |
| Alpha Tau Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease |
- Analyzing Alpha Tau's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alpha Tau's stock is overvalued or undervalued compared to its peers.
- Examining Alpha Tau's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alpha Tau's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alpha Tau's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alpha Tau's stock. These opinions can provide insight into Alpha Tau's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.